메뉴 건너뛰기




Volumn 288, Issue 4, 1998, Pages 509-518

Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, fleroxacin and broad-spectrum β-lactams against aerobe blood culture isolates

Author keywords

[No Author keywords available]

Indexed keywords


EID: 0032457547     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(98)80070-4     Document Type: Article
Times cited : (4)

References (19)
  • 1
    • 0027478091 scopus 로고
    • In vitro antimicrobial activity of CP-99, 219, a novel azabicyclo-naphthyridone
    • Briggs Gooding, B. and R. N. Jones: In vitro antimicrobial activity of CP-99, 219, a novel azabicyclo-naphthyridone. Antimicrob. Agents Chemother. 37 (1993) 349-353
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 349-353
    • Briggs Gooding, B.1    Jones, R.N.2
  • 2
    • 0029144805 scopus 로고
    • The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: A comparison with fluoroquinolone agents
    • Child, J., J. Andrews, F. Boswell, N. Brenwald, and R. Wise: The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J. Antimicrob. Chemother. 35 (1995) 869-876
    • (1995) J. Antimicrob. Chemother. , vol.35 , pp. 869-876
    • Child, J.1    Andrews, J.2    Boswell, F.3    Brenwald, N.4    Wise, R.5
  • 3
    • 0029903277 scopus 로고    scopus 로고
    • Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99, 219) against gram-positive cocci
    • Coque, T. M., K. V. Singh, and B. E. Murray: Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99, 219) against gram-positive cocci. J. Antimicrob. Chemother. 37 (1996) 1011-1016
    • (1996) J. Antimicrob. Chemother. , vol.37 , pp. 1011-1016
    • Coque, T.M.1    Singh, K.V.2    Murray, B.E.3
  • 5
    • 0031001953 scopus 로고    scopus 로고
    • Comparative in vitro activities of trovafloxacin (CP-99, 219) against 445 gram-positive isolates from patients with endocarditis and those with other blood-stream infections
    • Endtz, H. P., J. W. Mouton, J. G. den Hollander, N. van den Braak, and H. A. Verbrugh: Comparative in vitro activities of trovafloxacin (CP-99, 219) against 445 gram-positive isolates from patients with endocarditis and those with other blood-stream infections. Antimicrob. Agents Chemother. 41 (1997) 1146-1149
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1146-1149
    • Endtz, H.P.1    Mouton, J.W.2    Den Hollander, J.G.3    Van Den Braak, N.4    Verbrugh, H.A.5
  • 6
    • 0002977684 scopus 로고
    • Enterobacteriaceae: Introduction and identification
    • P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), American Society for Microbiology. Washington, D.C.
    • Farmer, J. J. III.: Enterobacteriaceae: introduction and identification, p. 438-449. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology. Washington, D.C. (1995)
    • (1995) Manual of Clinical Microbiology, 6th Ed. , pp. 438-449
    • Farmer III, J.J.1
  • 7
    • 0029162048 scopus 로고
    • Activity of quinolones against gram-positive cocci: Clinical features
    • Giamarellou, H.: Activity of quinolones against gram-positive cocci: clinical features. Drugs 49 (Suppl. 2) (1995) 58-66
    • (1995) Drugs , vol.49 , Issue.2 SUPPL. , pp. 58-66
    • Giamarellou, H.1
  • 8
    • 85030357028 scopus 로고    scopus 로고
    • Pseudomonas and Burkbolderia
    • P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), American Society for Microbiology. Washington, D. C.
    • Gilligan, P. H.: Pseudomonas and Burkbolderia, p. 509-519. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology. Washington, D. C.
    • Manual of Clinical Microbiology, 6th Ed. , pp. 509-519
    • Gilligan, P.H.1
  • 10
    • 0009648982 scopus 로고    scopus 로고
    • Double blind, randomized, multicenter study of nosocomial pseunomia (NOS) comparing trovafloaxin with ciprofloxacin ± clindamycin/metronidazole
    • abstr. LM-74, American Society for Microbiology, Washington, D. C.
    • Graham, D. R., T. Klein, A. Torres, M. Niedermann, and the Torvan Nosocomial Pneumonia Study Group: Double blind, randomized, multicenter study of nosocomial pseunomia (NOS) comparing trovafloaxin with ciprofloxacin ± clindamycin/metronidazole, abstr. LM-74, p.378. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D. C.
    • Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 378
    • Graham, D.R.1    Klein, T.2    Torres, A.3    Niedermann, M.4
  • 11
    • 0029818220 scopus 로고    scopus 로고
    • Antibacterial activity of trovafloxacin against Gram-positive blood culture isolates from nosocomial infections
    • Hussain Qadri, S. M. and Y. Ueno: Antibacterial activity of trovafloxacin against Gram-positive blood culture isolates from nosocomial infections. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 694-696
    • (1996) Eur. J. Clin. Microbiol. Infect. Dis. , vol.15 , pp. 694-696
    • Hussain Qadri, S.M.1    Ueno, Y.2
  • 12
    • 0002870339 scopus 로고
    • Staphylococcus and Micrococcus
    • P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), American Society for Microbiology, Washington, D.C.
    • Kloos, W. E. and T. L. Bannerman: Staphylococcus and Micrococcus, p.282-298. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. (1995)
    • (1995) Manual of Clinical Microbiology, 6th Ed. , pp. 282-298
    • Kloos, W.E.1    Bannerman, T.L.2
  • 13
    • 0002448786 scopus 로고    scopus 로고
    • Efficacy of trovafloxacin in patients with community acquired pneumonia due to penicillin susceptible and resistant S. pneumoniae
    • abstr. LM-71, American Society for Microbiology, Washington, D. C.
    • Mandell, L., D. W. Hopkins, and S. Hopkins: Efficacy of trovafloxacin in patients with community acquired pneumonia due to penicillin susceptible and resistant S. pneumoniae, abstr. LM-71, p. 377. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D. C. (1997)
    • (1997) Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 377
    • Mandell, L.1    Hopkins, D.W.2    Hopkins, S.3
  • 14
    • 0025753375 scopus 로고
    • Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lympomas and solid tumors
    • Meunier, F., S. H. Zinner, H. Gaya, T. Calandra, C. Viscoli, J. Klastersky, M. Glauser, and the European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group: Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lympomas and solid tumors. Antimicrob. Agents Chemother. 35 (1991) 873-878
    • (1991) Antimicrob. Agents Chemother. , vol.35 , pp. 873-878
    • Meunier, F.1    Zinner, S.H.2    Gaya, H.3    Calandra, T.4    Viscoli, C.5    Klastersky, J.6    Glauser, M.7
  • 15
    • 0037710633 scopus 로고    scopus 로고
    • Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa
    • National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa (1997)
    • (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th Ed.
  • 16
    • 0027999053 scopus 로고
    • Activity of CP 99, 219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against 489 anaerobes
    • Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum: Activity of CP 99, 219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against 489 anaerobes. Antimicrob. Agents Chemother. 38 (1994) 2471-2476
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 2471-2476
    • Spangler, S.K.1    Jacobs, M.R.2    Appelbaum, P.C.3
  • 17
    • 0030756870 scopus 로고    scopus 로고
    • The in-vitro activity of trovafloxacin, a new fluoroquinolone, against gram-positive bacteria
    • Sefton, A. M., J. P. Maskell, A. M. Rafay, A. Wholey, and J. D. Williams: The in-vitro activity of trovafloxacin, a new fluoroquinolone, against gram-positive bacteria. J. Antimicrob. Chemother. 39 (Suppl. B.) (1997) 57-62
    • (1997) J. Antimicrob. Chemother. , vol.39 , Issue.SUPPL. B. , pp. 57-62
    • Sefton, A.M.1    Maskell, J.P.2    Rafay, A.M.3    Wholey, A.4    Williams, J.D.5
  • 18
    • 0029092852 scopus 로고
    • Pharmacokinetics and safety of trovafloxacin (CP 99, 219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers
    • Teng, R., S. C. .Harris, D. E. Nix, J. J. Schentag, G. Foulds, and T. E. Liston: Pharmacokinetics and safety of trovafloxacin (CP 99, 219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J. Antimicrob. Chemother. 36 (1995) 385-394
    • (1995) J. Antimicrob. Chemother. , vol.36 , pp. 385-394
    • Teng, R.1    Harris, S.C.2    Nix, D.E.3    Schentag, J.J.4    Foulds, G.5    Liston, T.E.6
  • 19
    • 0030845019 scopus 로고    scopus 로고
    • Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods
    • Visalli, M. A., S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum: Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrob. Agents Chemother. 41 (1997) 1475-1481
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1475-1481
    • Visalli, M.A.1    Bajaksouzian, S.2    Jacobs, M.R.3    Appelbaum, P.C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.